Department of Surgery, Myongji Hospital, Goyang, Korea.
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea.
J Korean Med Sci. 2018 Jan 29;33(5):e39. doi: 10.3346/jkms.2018.33.e39.
As the need for the organ donation increases, strategies to increase kidney transplantation (KT) through expanded living donation have become essential. These include kidney paired donation (KPD) programs and desensitization in incompatible transplantations. KPD enables kidney transplant candidates with incompatible living donors to join a registry with other incompatible pairs in order to find potentially compatible living donor. Positive cross match and ABO incompatible transplantation has been successfully accomplished in selective cases with several pre-conditionings. Patients who are both difficult-to-match due to broad sensitization and hard-to-desensitize because of donor conditions can often be successfully transplanted through a combination of KPD and desensitization. According to the existing data, KPD can increase the number of KTs from living donors with excellent clinical results. This is also a cost-effective treatment as compared with dialysis and desensitization protocols. We carried out 3-way KPD transplantation with one highly sensitized, positive cross match pair and with two ABO incompatible pairs. Herein we report our first successful 3-way KPD transplantation in a single center. To maximize donor-recipient matching and minimize immunologic risk, KPD programs should use proper algorithms with desensitization to identify optimal donor with simultaneous two-, three- or more complex multi-way exchanges.
随着器官捐赠需求的增加,通过扩大活体捐赠来增加肾移植 (KT) 的策略变得至关重要。这些策略包括肾配对捐赠 (KPD) 计划和不相容移植中的脱敏。KPD 使具有不相容活体供体的肾移植候选者能够与其他不相容的配对一起加入登记处,以寻找潜在的相容活体供体。在经过几种预处理的选择性病例中,已经成功地完成了阳性交叉匹配和 ABO 不相容移植。由于广泛致敏而难以匹配且由于供体条件而难以脱敏的患者,通常可以通过 KPD 和脱敏的组合成功移植。根据现有数据,KPD 可以增加具有出色临床结果的活体供者的 KT 数量。与透析和脱敏方案相比,这也是一种具有成本效益的治疗方法。我们进行了 3 对 KPD 移植,其中包括 1 对高度致敏、阳性交叉匹配的配对和 2 对 ABO 不相容的配对。在此,我们报告了在单个中心进行的首例成功的 3 对 KPD 移植。为了最大限度地匹配供体和受者,并最小化免疫风险,KPD 计划应使用适当的算法和脱敏来识别最佳供体,同时进行两、三或更多复杂的多对交换。